Improving diagnostics of rare genetic diseases with NGS approaches
- PMID: 33452619
- PMCID: PMC8141085
- DOI: 10.1007/s12687-020-00500-5
Improving diagnostics of rare genetic diseases with NGS approaches
Abstract
According to a rough estimate, one in fifteen people worldwide is affected by a rare disease. Rare diseases are therefore common in clinical practice; however, timely diagnosis of rare diseases is still challenging. Introduction of novel methods based on next-generation sequencing (NGS) technology offers a successful diagnosis of genetically heterogeneous disorders, even in case of unclear clinical diagnostic hypothesis. However, the application of novel technology differs among the centres and health systems significantly. Our goal is to discuss the impact of the implementation of NGS in the diagnosis of rare diseases and present advantages along with challenges of diagnostic approach. Systematic implementation of NGS in health systems can significantly improve the access of patients with rare diseases to diagnosis and reduce the dependence of national health systems for cross-border collaboration.
Keywords: Diagnostics; Healthcare system; Next generation sequencing; Rare diseases.
Conflict of interest statement
The authors declare that they have no conflict of interest.
References
-
- Australian Genomics Health Aliiance (AGHA) Patient Archive (n.d.) Patient Archive. https://mme.australiangenomics.org.au/
LinkOut - more resources
Full Text Sources
Other Literature Sources